用于治疗心肌梗塞的粘合和导电水凝
Jialiang Zhao1,2, Ying Chen1, Yuanyuan Qin1,2
1Institute of Biomedical Engineering, College of Medicine, Southwest Jiaotong University, Chengdu, Sichuan, 610031, China.
Macromolecular rapid communications
|January 13, 2025
概括
能够粘附于心脏组织的导电性水凝为心肌梗塞 (MI) 后的损伤修复提供了有希望的解决方案. 这些材料提高了电导率,有助于心脏修复和预防心律失常.
科学领域:
- 生物材料科学 生物材料科学
- 心血管研究研究心血管研究
- 组织工程是组织工程.
背景情况:
- 心肌梗塞 (MI) 导致痕组织的形成,损害心脏电导率并导致心律失常.
- 传统的水凝缺乏导电性,限制了它们在心脏组织工程中用于心脏中风修复的使用.
- 需要增强的水凝来弥合受损心脏组织中的电信号.
研究的目的:
- 审查创建导电和粘合性水凝用于心肌梗塞 (MI) 修复的策略.
- 讨论这些先进的水凝在心脏组织工程中的应用.
- 确定这一领域的挑战和未来的研究方向.
主要方法:
- 关于导电和粘合性水凝的科学文献的综述.
- 专注于将导电性和粘附性赋予水凝的策略.
- 在心肌梗塞 (MI) 修复的背景下对水凝应用的分析.
主要成果:
- 导电和粘合性水凝显示出在心肌梗塞中恢复电信号传输的潜力.
- 这些水凝可以改善对心脏组织的粘附性,从而实现稳定的电气连接.
- 导电性和粘附的结合促进了同步收缩和心肌修复.
结论:
- 导电和粘合性水凝是一种有前途的治疗策略,用于心肌梗塞 (MI) 修复.
- 需要进一步发展,以克服创造有效的基于水凝的心脏疗法的挑战.
- 未来的研究应该专注于优化水凝特性,以改善心脏功能和再生.
相关概念视频
Coagulation
Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...
Heart Failure Drugs: Inotropic Agents
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.


